Brief: Anixa Biosciences Announces Presentation Of Its Ovarian Cancer Car-T Therapy Clinical Trial
30/03/2026 14:36
March 30 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES ANNOUNCES PRESENTATION OF ITS OVARIAN CANCER CAR-T THERAPY CLINICAL TRIAL AT THE SOCIETY OF GYNECOLOGIC ONCOLOGY ANNUAL MEETING ON WOMEN'S CANCER Source text: ID:nPn4vhHRva Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine